PD-1 and ICOS coexpression identifies tumor-reactive CD4+ T cells in human solid tumorsJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-06-1540OAAI
PD-1 and ICOS co-expression identifies tumor-reactive CD4 Th cells in human solid tumorsJOURNAL OF IMMUNOLOGYIF3.42022-05-010PRE
Neoadjuvant anti-OX40 (MEDI6469) therapy in patients with head and neck squamous cell carcinoma activates and expands antigen-specific tumor-infiltrating T cellsNATURE COMMUNICATIONSIF15.72021-02-16112OAAI
Gut bacterial tyrosine decarboxylases restrict levels of levodopa in the treatment of Parkinson's diseaseNATURE COMMUNICATIONSIF15.72019-01-18340OAAI